跳至主要内容
临床试验/CTRI/2021/07/034918
CTRI/2021/07/034918尚未招募未知

Comparing the effectiveness of LM scale potency versus centesimal scale potency of individualized homoeopathic medication in modifying the susceptibility of children suffering with ADHD by randomized experimental design - LM scale

irav Rajnikant Rughani0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ADHD with other physical co-morbidity.
  • If child is taking other medical treatment then it must be pass minimum 3 months and the effect must be calculated before homoeopathic treatment started.
  • If child is on any other therapy like Behaviour therapy, physiotherapy, occupational therapy then we will continue it but, it must be pass 6 months and assessment of changes with that therapy will be evaluated before of the intervention of homoeopathic treatment then only that child will included in the study.

排除标准

  • Epilepsy and other neuro-biological illness which can affect the children hyperactive behaviour will be excluded for the study.
  • Children, who have recent history of onset of other mode of therapy that have direct effect on modification of hyperactive behaviour of child will not be taken in for study.
  • If children are suffering with other co-morbidity with ADHD like Autism spectrum disorder, history of drug abuse, seizure, conduct disorder, oppositional defiant disorder, mood disorder (childhood depression), tics disorder and anxiety disorder will not be taken into study.

研究者

发起方
irav Rajnikant Rughani

相似试验